PD-L2 is expressed on activated human T cells and regulates their function

被引:98
|
作者
Messal, Nassima [1 ,2 ,3 ]
Serriari, Nacer-Eddine [1 ,2 ,3 ]
Pastor, Sonia [1 ,2 ,3 ]
Nunes, Jacques A. [1 ,2 ,3 ]
Olive, Daniel [1 ,2 ,3 ]
机构
[1] Ctr Rech Cancerol Marseille, Inst Natl Sante & Rech Med, U891, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, F-13009 Marseille, France
[3] Univ Mediterranee, F-13009 Marseille, France
关键词
T cells; Cell activation; Costimulatory molecules; PD-L2; B7; LIGANDS; SUSCEPTIBILITY; INFECTION; RESPONSES;
D O I
10.1016/j.molimm.2011.06.436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T-cell activation and proliferation are regulated by cosignaling adhesion molecules involved in positive or negative signals. Programmed death (PD)-1 is one of immune inhibitory molecules that is expressed in activated T cells and is a promising target for immunotherapy. Both PD-1 ligands, PD-L1 and PD-L2 are expressed on antigen presenting cells (APCs) involved in the dialogue between a T cell and an APC. Here, we analysed the expression of these ligands, especially for PD-L2, on T cells. PD-L2 appears to be expressed on activated CD4 and CD8T cell subsets. Moreover, as PD-1 molecule, PD-L2 engagement at the surface of T cells is able to down-modulate cytokine production and cell proliferation. These observations indicate that PD-L2 is expressed following activation and is involved in the regulation of T cell function, highlighting the level of complexity in the T cell cosignaling network. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2214 / 2219
页数:6
相关论文
共 50 条
  • [31] TLR2 Directing PD-L2 Expression Inhibit T Cells Response in Schistosoma japonicum Infection
    Gao, Yanan
    Chen, Lin
    Hou, Min
    Chen, Yingying
    Ji, Minjun
    Wu, Haiwei
    Wu, Guanling
    PLOS ONE, 2013, 8 (12):
  • [32] PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
    Francisco, Loise M.
    Salinas, Victor H.
    Brown, Keturah E.
    Vanguri, Vijay K.
    Freeman, Gordon J.
    Kuchroo, Vijay K.
    Sharpe, Arlene H.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (13): : 3015 - 3029
  • [33] Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells
    Murayama, Masanori A.
    Takada, Erika
    Takai, Kenji
    Arimitsu, Nagisa
    Shimizu, Jun
    Suzuki, Tomoko
    Suzuki, Noboru
    PLOS ONE, 2022, 17 (01):
  • [34] Mediated expression of the immunomodulatory molecule PD-L2 in human islets maintains stable in vitro islet function
    Rojas, Darling M.
    Krishnan, Ravi
    Coates, P. Toby
    XENOTRANSPLANTATION, 2009, 16 (05) : 400 - 400
  • [35] Association of PD-L2 expression in human tumors with atezolizumab activity.
    Schmid, Peter
    Hegde, Priti S.
    Zou, Wei
    Kowanetz, Marcin
    Mariathasan, Sanjeev
    Molinero, Luciana
    Gadgeel, Shirish M.
    Powles, Thomas
    van der Heijden, Michiel Simon
    Fasso, Marcella
    O'Hear, Carol
    Ballinger, Marcus
    Fine, Gregg Daniel
    Sandler, Alan
    Chen, Daniel S.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Inhibition of PI3Kδ Differentially Regulates Poly I:C- and Human Metapneumovirus-Induced PD-L1 and PD-L2 Expression in Human Bronchial Epithelial Cells
    Ogawa, Tomohiro
    Kan-o, Keiko
    Shiota, Ayaka
    Fujita, Akitaka
    Ishii, Yumiko
    Fukuyama, Satoru
    Matsumoto, Koichiro
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [37] Cloning and Identification of Two Novel Splice Variants of Human PD-L2
    Xian-Hui HE#*
    1Institute of Bioengineering
    Acta Biochimica et Biophysica Sinica, 2004, (04) : 284 - 289
  • [38] HUMAN PD-L2 TRIGGERS A UNIQUE T CELL INHIBITORY PROGRAM THROUGH PD-1 ENGAGEMENT DISTINCT FROM THAT OF PD-L1
    Srinivasamani, Anupallavi
    Curran, Michael
    Liu, Qinying
    Hegde, Shwetha
    Chen, Chao-Hsien
    Rajapakshe, Kimal
    Coarfa, Cristian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A248 - A248
  • [39] EXPRESSION OF IMMUNE CHECKPOINT MOLECULES (PD-1, PD-L1, AND PD-L2) ON BONE MARROW T CELLS IN ACUTE MYELOID LEUKEMIA
    You, E.
    Park, C. -J.
    Cho, Y. -U.
    Yoon, C. H.
    Jang, S.
    Im, H. J.
    Seo, J. J.
    Lee, J. -H.
    Lee, K. -H.
    HAEMATOLOGICA, 2017, 102 : 373 - 374
  • [40] Cloning and identification of two novel splice variants of human PD-L2
    He, XH
    Liu, Y
    Xu, LH
    Zeng, YY
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2004, 36 (04) : 284 - 289